Health Care Equipment & Supplies · NYSE
RMDResmed Inc
- Last close
- $239.53 +0.3%
- 52-week range
- $180.26 to $277.67
- Market cap
- $33.7B
- Next earnings
- Not scheduled
Fiscal 2026 at a glance
Stock price
Valuation vs its own 10 years
Below its 10-year median on all 4 multiples
Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.
Valuation
- P/E
- 21.8x
- Earnings yield
- 4.6%
- Price / sales
- 5.9x
- Price / book
- 5.7x
- Price / operating cash flow
- 19.0x
- EV / EBITDA
- 15.8x
- EV / sales
- 5.8x
- Free cash flow yield
- 4.8%
Profitability
- Gross margin
- 61.1%
- Operating margin
- 33.0%
- Net margin
- 27.8%
- Return on equity
- 26.8%
- Return on capital
- 23.6%
Growth per year
- Revenue, 3 years
- +10.2%
- Revenue, 5 years
- +12.1%
- Revenue, 9 years
- +11.8%
- EPS, 3 years
- +19.6%
Balance sheet
- Cash and investments
- $1.01B
- Total debt
- $410M
- Net cash
- $601M
- Debt / equity
- 0.07x
- Current ratio
- 2.65x
Shares and dividend
- Shares outstanding
- 141M
- Share count, 5 years
- -0.3%
- Beta, 1 year
- 0.49
- Dividend yield
- 1.0%
- Dividend per share, TTM
- $2.46
- Payout ratio
- 22.4%
Ten years of the business
Last 40 quarters, fiscal 2017 to 2026 and after. Hover a bar for its quarter.
Fiscal years 2017 to 2026.
Where the revenue comes from
Sleep and Breathing Health went from 88% to 88% of revenue in 3 years
Share of revenue by product line, fiscal 2023 to 2026, as reported in the 10-K.
| Product line | Revenue | Share | vs FY25 |
|---|---|---|---|
| Sleep and Breathing Health | $4.98B | 88.0% | +10% |
| Residential Care Software | $676M | 12.0% | +5% |
Health Care Equipment & Supplies peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | $188B | +10% | 13.8% | 40.4x | 3.9x | 60th percentile |
| DHR Danaher Corp | $164B | +6% | 20.4% | 38.1x | 6.4x | 65th percentile |
| ISRG Intuitive Surgical Inc | $154B | +20% | 28.4% | 53.7x | 13.3x | 48th percentile |
| MDT Medtronic plc | $132B | +10% | 18.1% | 25.3x | 3.5x | 20th percentile |
| SYK Stryker Corp | $118B | +8% | 20.7% | 33.0x | 4.5x | 30th percentile |
| RMD Resmed Inc | $33.7B | +9% | 33.0% | 21.8x | 5.9x | 8th percentile |
The company
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- CEO
- Michael Farrell
- Founded
- 1989
- Headquarters
- San Diego, CA
- Fiscal year ends
- June
- Website
- resmed.com
What it does
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.
Description from Wikipedia (CC BY-SA).
Around the numbers
What the rest of EdgeStacker knows about RMD.